Skip to main content

Table 2 Characteristics of patients according to the success or failure of the first separation attempt from high-flow nasal oxygen therapy

From: Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study

Variables

Success

(n = 168)

Failure

(n = 22)

p value

Baseline characteristics

 Age, years

61 ± 15

61 ± 14

0.93

 Gender, female, n

55 (33%)

6 (27%)

0.81

 Simplified acute physiology score II, points

36 ± 12

40 ± 13

0.22

 Sequential organ failure assessment score, points

5 ± 3

5 ± 4

0.74

Comorbidities, n

 Chronic cardiac failure

32 (19%)

4 (18%)

> 0.99

 Chronic respiratory failure

  Obstructive

31 (18%)

5 (23%)

0.85

  Restrictive

10 (5.9%)

2 (9.1%)

0.92

 Immunosuppression

56 (33%)

8 (36%)

0.97

Main reason for acute respiratory failure, n

 Pneumonia

79 (47%)

16 (73%)

0.04

 Cardiogenic pulmonary edema

28 (17%)

1 (4.5%)

0.21

 Extrapulmonary sepsis

26 (15%)

1 (4.5%)

0.32

 Acute exacerbation of chronic respiratory failure

9 (5.4%)

1 (4.5%)

> 0.99

 Pulmonary embolism

7 (4.2%)

1 (4.5%)

> 0.99

 Shock

4 (2.4%)

0 (0%)

> 0.99

 Neurological failure

4 (2.4%)

0 (0%)

> 0.99

 Drug abuse

2 (1.2%)

0 (0%)

> 0.99

 Other diagnoses

1 (6.0%)

2 (9.1%)

0.63

Characteristics before the first separation attempt from HFOT

 Bilateral infiltrates at chest X-ray, n

59 (35%)

10 (45%)

0.48

 Vasoactive drugs, n

8 (5%)

0 (0%)

0.63

 Length of treatment with HFOT, hours

41 (23–72)

56 (39–80)

0.26

Last clinical and biological parameters before the first separation attempt from HFOT

 Flow, L/min

42 ± 8

43 ± 8

0.54

 FiO2 set, %

39 ± 7

48 ± 16

0.02

 Temperature, °C

37.3 ± 0.8

37.4 ± 0.8

0.54

 Systolic arterial pressure, mmHg

125 ± 19

127 ± 19

0.68

 Heart rate, beats/min

92 ± 19

94 ± 20

0.60

 Respiratory rate, breaths/min

21 ± 5

22 ± 5

0.59

 Pulse oximetry, %

96 ± 2

96 ± 2

0.36

 SpO2/FiO2, %

254 ± 45

217 ± 53

0.004

 ROX index

12.7 ± 1.2

10.2 ± 3.0

0.002

 PaO2, mmHg

95 ± 33

96 ± 33

0.92

 PaCO2, mmHg

35 ± 7

36 ± 8

0.68

 pH

7.45 ± 0.05

7.44 ± 0.05

0.72

 Serum bicarbonate, mmol/L

24 ± 5

24 ± 5

0.99

 Last PaO2/FiO2 under HFOT, mmHg

226 ± 64

210 ± 72

0.35

 Sequential organ failure assessment score, points

3 ± 2

1 ± 2

0.27

First clinical parameters under standard oxygen after the separation attempt from HFOT

 Flow, L/min

4 ± 1

5 ± 1

0.02

 Temperature, °C

37.4 ± 0.7

37.4 ± 0.9

0.92

 Systolic arterial pressure, mmHg

125 ± 18

131 ± 17

0.15

 Heart rate, beats/min

91 ± 18

92 ± 16

0.75

 Respiratory rate, breaths/min

23 ± 5

22 ± 5

0.39

 Pulse oximetry, %

96 ± 3

95 ± 3

0.13

 SpO2/FiO2, %

286 ± 39

263 ± 28

0.001

 ROX index

13.3 ± 3.9

12.7 ± 3.2

0.47

Outcomes

 Total length of HFOT treatment, h

41 (23–72)

84 (61–118)

< 0.0001

 ICU length of stay, days

5 (4–8)

10 (7–12)

< 0.0001

 Time from HFOT separation success to ICU discharge, days

2 (1–3)

2 (2–3)

0.21

  1. HFOT high-flow nasal oxygen therapy, ICU intensive-care unit, FiO2 fraction of inspired oxygen, PaO2 partial pressure in oxygen, SpO2 oxygen saturation, ROX SpO2/FiO2 to respiratory rate